10 Analysts Have This To Say About Kenvue
Portfolio Pulse from Benzinga Insights
Analysts have provided diverse evaluations of Kenvue (NYSE:KVUE) over the past three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased to $24.1. Kenvue, a leading consumer health company, faces challenges with a slight revenue decline but maintains strong financial metrics like net margin and ROE.
October 22, 2024 | 6:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Kenvue has received mixed analyst ratings, with a majority being bullish or somewhat bullish. The average price target has increased to $24.1, indicating positive sentiment. Despite a slight revenue decline, Kenvue's strong financial metrics like net margin and ROE suggest resilience.
The increase in the average price target and the majority of bullish ratings suggest a positive short-term outlook for Kenvue. The company's strong financial metrics, despite a slight revenue decline, further support this positive sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100